Glucotrack, Inc. Quarterly Return On Equity in % from Q2 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Glucotrack, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2012 to Q3 2024.
  • Glucotrack, Inc. Return On Equity for the quarter ending September 30, 2024 was 1.6K %.
  • Glucotrack, Inc. annual Return On Equity for 2023 was -172 %, a 6.69% decline from 2022.
  • Glucotrack, Inc. annual Return On Equity for 2022 was -161 %, a 168% decline from 2021.
  • Glucotrack, Inc. annual Return On Equity for 2021 was -60.1 %, a 124% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 1.6K +1.76K Jul 1, 2024 Sep 30, 2024
Q2 2024 -825 -660 -400% Apr 1, 2024 Jun 30, 2024
Q1 2024 -207 +65.6 +24.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -172 -10.8 -6.69% Oct 1, 2023 Dec 31, 2023
Q3 2023 -164 -39.6 -31.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -165 -70 -73.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -273 -199 -271% Jan 1, 2023 Mar 31, 2023
Q4 2022 -161 -101 -168% Oct 1, 2022 Dec 31, 2022
Q3 2022 -125 -80.2 -180% Jul 1, 2022 Sep 30, 2022
Q2 2022 -95 -58.4 -159% Apr 1, 2022 Jun 30, 2022
Q1 2022 -73.5 -42.9 -140% Jan 1, 2022 Mar 31, 2022
Q4 2021 -60.1 -33.3 -124% Oct 1, 2021 Dec 31, 2021
Q3 2021 -44.5 -106 -172% Jul 1, 2021 Sep 30, 2021
Q2 2021 -36.6 -123 -142% Apr 1, 2021 Jun 30, 2021
Q1 2021 -30.6 -206 -117% Jan 1, 2021 Mar 31, 2021
Q4 2020 -26.8 +258 +90.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 61.8 -434 -87.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 86.5 -71.8 -45.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 175 +75.7 +76% Jan 1, 2020 Mar 31, 2020
Q4 2019 -284 -336 -652% Oct 1, 2019 Dec 31, 2019
Q3 2019 496 +595 Jul 1, 2019 Sep 30, 2019
Q2 2019 158 +253 Apr 1, 2019 Jun 30, 2019
Q1 2019 99.5 +196 Jan 1, 2019 Mar 31, 2019
Q4 2018 51.5 +124 Oct 1, 2018 Dec 31, 2018
Q3 2018 -99.1 -168 -245% Jul 1, 2018 Sep 30, 2018
Q2 2018 -94.6 -161 -243% Apr 1, 2018 Jun 30, 2018
Q1 2018 -96.3 -160 -250% Jan 1, 2018 Mar 31, 2018
Q4 2017 -72.4 -130 -227% Oct 1, 2017 Dec 31, 2017
Q3 2017 68.5 -0.1 -0.15% Jul 1, 2017 Sep 30, 2017
Q2 2017 66.1 -7.68 -10.4% Apr 1, 2017 Jun 30, 2017
Q1 2017 64.1 -23.1 -26.5% Jan 1, 2017 Mar 31, 2017
Q4 2016 57.1 -51.9 -47.6% Oct 1, 2016 Dec 31, 2016
Q3 2016 68.6 -36.5 -34.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 73.7 -28.6 -27.9% Apr 1, 2016 Jun 30, 2016
Q1 2016 87.2 +129 Jan 1, 2016 Mar 31, 2016
Q4 2015 109 +151 Oct 1, 2015 Dec 31, 2015
Q3 2015 105 +65.5 +165% Jul 1, 2015 Sep 30, 2015
Q2 2015 102 +62.2 +155% Apr 1, 2015 Jun 30, 2015
Q1 2015 -42.1 -165 -134% Jan 1, 2015 Mar 31, 2015
Q4 2014 -42.1 -236 -122% Oct 1, 2014 Dec 31, 2014
Q3 2014 39.6 -98 -71.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 40.1 -161 -80.1% Apr 1, 2014 Jun 30, 2014
Q1 2014 123 -251 -67.1% Jan 1, 2014 Mar 31, 2014
Q4 2013 194 -897 -82.2% Oct 1, 2013 Dec 31, 2013
Q3 2013 138 +2.49K Jul 1, 2013 Sep 30, 2013
Q2 2013 201 +590 Apr 1, 2013 Jun 30, 2013
Q1 2013 375 Jan 1, 2013 Mar 31, 2013
Q4 2012 1.09K Oct 1, 2012 Dec 31, 2012
Q3 2012 -2.35K Jul 1, 2012 Sep 30, 2012
Q2 2012 -389 Apr 1, 2012 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.